Oct 13, 2010 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Surgical pathologists could gain new tool to diagnose many types of cancers It might soon be possible to determine the HER2 status of breast cancer patients from blood samples rather than tissue biopsies. If this new technology proves feasible, it would give surgical pathologists and medical laboratories a different, and possibly less complex, methodology to use when assessing a case of breast cancer. In its report about the study, Medscape Medical News, wrote that “HER2 status derived from...
